Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 224, pseudogene (KRT224P) is part of the type I keratin gene family in humans, but functions as a pseudogene, meaning it does not encode an active or functional keratin protein[1][2]. Keratin pseudogenes are remnants of ancestral genes and do not contribute directly to keratin filament formation or structural roles in epithelial cells[2]. KRT224P is not expressed as a protein and currently has no known biological function, role in disease, or therapeutic relevance[1][2]. It is not regarded as a therapeutic target, biomarker, or druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 224, pseudogene (KRT224P).